<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>The Roslin Institute</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BE941673-99F3-43CA-A4BB-66DA04A4915C"><gtr:id>BE941673-99F3-43CA-A4BB-66DA04A4915C</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Digard</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FD%2F20241865"><gtr:id>A96C633B-CEE2-4D91-B9F8-0D6FCBC694BE</gtr:id><gtr:title>The influence of dual infections on viral load and disease severity</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/D/20241865</gtr:grantReference><gtr:abstractText>Endemic and exotic virus diseases are threats to food security and, in some cases, potential zoonoses. Laboratory studies of virus pathogenesis rely on infection of ?clean? animals. In nature, however, secondary infections or underlying persistent infections are likely to play a major role in determining the outcome of infection. Understanding how viruses and other pathogens interact within target species and disease transmitting vectors may lead to insights into prevention of virus transmission, infection or disease.</gtr:abstractText><gtr:fund><gtr:end>2017-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>268468</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Flu Fighters public exhibition stand</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F2F54737-F07B-4BEA-B59C-3185423501D6</gtr:id><gtr:impact>4. With &amp;pound;10k BBSRC funding, ISPG4-funded researchers jointly developed 'Flu-Fighters', an interactive exhibit suitable for children and adults highlighting our research to create influenza-resistant farm animals, develop improved vaccines and diagnostic tests, and understand the role of viral and host factors in the outcome of infection. This was run over three days in November 2014 at the Great British Bioscience Festival (visited by over 6500 people) as part of BBSRC's 20th anniversary programme. ISPG4 scientists were involved in running it again at the Royal Society's 2015 Summer Science Exhibition in London.</gtr:impact><gtr:outcomeId>56e03887eb36d2.50751634</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Edinburgh Science Festival, Flu Fighters</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>FCDCABF4-C377-4ADA-9A38-AC36D5F629FC</gtr:id><gtr:impact>Participated in Flu Fighters during the Edinburgh Science Festival 2015.
We showcased the exhibit 'Flu Fighters' at the festival. The 'Flu Fighters' exhibit focuses on influenza viruses and the science behind the varied approaches to combating flu being developed at Roslin and Pirbright. It showcases current research including GM animals, novel approaches to vaccines and diagnostic tests and host/virus genetics.
The exhibit also demonstrates how flu transmits from animals to humans and highlight the challenges of preventing large-scale outbreaks.The 'Flu Fighters' exhibit provides an opportunity for visitors to run diagnostic tests on a chicken, design their own flu virus and discuss the pros and cons of genetic modification of animals.
Over 100 people attended the morning and the activities sparked questions from both children and parents/carers. A better understanding of the problem for the poultry industry, eco system (wild birds) and human health was reported back.</gtr:impact><gtr:outcomeId>56d58bbf576e50.79352496</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>367000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>CALL: INTEGRATING AND OPENING RESEARCH INFRASTRUCTURES OF EUROPEAN INTEREST</gtr:description><gtr:end>2022-03-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>H2020-INFRAIA-2016-1 project number 731014</gtr:fundingRef><gtr:id>9F0AAC4C-119D-4DD0-9AA2-647B8454CB07</gtr:id><gtr:outcomeId>58c9abde184e71.27482896</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ZEIDA</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Zoetis</gtr:fundingOrg><gtr:id>EA0427F4-64C6-4015-A5BF-79BC6F15E074</gtr:id><gtr:outcomeId>58c8558a5a0fb2.73965493</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>804</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Mobility grant for staff teaching/training</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>erasmus +</gtr:fundingOrg><gtr:id>B47E0160-089A-4515-9352-D1428ED03106</gtr:id><gtr:outcomeId>58c902c42e9630.81744595</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>BBSRC strategic investment at Roslin via this and other Institute
Strategic Programmes has sustained expertise and facilities that have
attracted substantial inward investment at Easter Bush. This has recently
included &amp;pound;15M Gates Foundation funding to establish the Centre for
Tropical Livestock Genetics &amp;amp; Health to implement genetic gain and
treatments in support of farmers in low- and middle-income farmers,
including to control endemic and zoonotic diseases. It has also driven
dozens of productive collaborations with industry via contracts and
leveraging schemes, leading to &amp;pound;10M private equity investment to form
Roslin Technologies to commercialise our research and construction of a
new &amp;pound;32M Innovation Centre adjacent to the Institute to engage and grow
businesses. Moreover, the expertise supported by this funding has
attracted major investment in Agri-Tech Centres at Easter Bush funded by
InnovateUK (Centre for Innovation Excellence in Livestock &amp;amp; Agri-EPI).
These Centres will increase national capacity for infectious challenge in
farmed animals, gene editing and collection of novel phenotypes and be
linked to stakeholders throughout the food supply chain.</gtr:description><gtr:firstYearOfImpact>2016</gtr:firstYearOfImpact><gtr:id>B0F69F86-31E0-486A-BB85-92FB9CDB5F0E</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56e053318f7153.52060790</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Education,Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We investigated the effect of on-going herpesvirus infection on acute influenza A virus infection in a mouse model. We showed that mice latent infected with a gammaherpesvirus experienced less severe infections than naive mice. The mechanism of protection was explored using protein and QPCR arrays and showed that a primed innate immune response against the DNA virus provided for an elevated innate immune response in co-infected mice which prevented viral spread and controlled virus replication. We also investigated the effect of parasitic helminth infection on influenza respiratory disease. These experiments showed that the outcome was dependent on the stage of worm lifecycle such that co-infection either alleviated or exacerbated disease. 

An ongoing study has examined the pathogenesis of Staphylococcus aureus and influenza A virus co-infection. Secondary infection of influenza-infected individuals by pathogens such as Staphylococcus aureus and Streptococcus pneumonia is a major cause of morbidity and mortality in human populations. We have identified a secreted enzyme of S. aureus that enhances influenza replication in primary cells from humans and chickens in vitro, suggesting that it may contribute to increased severity during co-infection. We are currently examining the mechanism involved in this activity. 

Our epidemiological studies into bovine respiratory disease complex (BRD) have established that in Kenya, there are positive associations between infectious bovine rhinotracheitis virus (IBR), bovine parainfluenza virus Type 3 (PIV3) and bovine viral diarrhoea virus (BVDV) in East African Shorthorn Zebu calves.</gtr:description><gtr:exploitationPathways>The coinfection studies (in the laboratory and the field) have implications for the use of live vaccines, particularly in countries where helminth infections are common, as well as for control strategies for complex disease syndromes.
 
We are exploring a potential application of the effect of the Staphylococcus aureus protein that enhances influenza A virus infection to enhance the yield of influenza vaccines that are propagated in chicken eggs. We established that addition of a recombinant form of the staphylococcal protein to eggs can increase the yield of influenza vaccine strains by 3-fold. This could potentially contribute to improved capacity and reduced costs for influenza vaccine production. We plan to further investigate the potential translation and commercial viability of the application.</gtr:exploitationPathways><gtr:id>4CB232A6-FEFA-4C0C-8B12-0BF39679D0E5</gtr:id><gtr:outcomeId>56e04a99b18c10.04754514</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We improved a caesarean-derived, colostrum deprived pig model to ensure that animal welfare and survivability of pigs increases.</gtr:description><gtr:id>F9338CD0-D305-40EF-AF8F-DE92A1B22822</gtr:id><gtr:impact>Survivability of pigs increased from 50% to 90-100%</gtr:impact><gtr:outcomeId>58c7a7d6ca10a2.40533419</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CDCD pig model</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>417C4979-07A4-4E33-B638-F830331CE41E</gtr:id><gtr:title>Identification and characterization of multiple porcine astrovirus genotypes in Hunan province, China.</gtr:title><gtr:parentPublicationTitle>Archives of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31f793f4cbbbf9c5864efd61bd888593"><gtr:id>31f793f4cbbbf9c5864efd61bd888593</gtr:id><gtr:otherNames>Xiao CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0304-8608</gtr:issn><gtr:outcomeId>58c6d1126c9fa1.03948520</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CACF5F9-CF06-4674-96F1-658BEA7FB4B9</gtr:id><gtr:title>Seroprevalence of respiratory viral pathogens of indigenous calves in Western Kenya.</gtr:title><gtr:parentPublicationTitle>Research in veterinary science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84efae428c491088e70ce34d0329fbed"><gtr:id>84efae428c491088e70ce34d0329fbed</gtr:id><gtr:otherNames>Callaby R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0034-5288</gtr:issn><gtr:outcomeId>58c99a832584e7.68090689</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF3068D2-74EF-4627-AB8B-B18EF4E82EA4</gtr:id><gtr:title>Association of concurrent porcine circovirus (PCV) 2a and 2b infection with PCV associated disease in vaccinated pigs.</gtr:title><gtr:parentPublicationTitle>Research in veterinary science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa72bea1b47c5b3dffdd987420836f27"><gtr:id>aa72bea1b47c5b3dffdd987420836f27</gtr:id><gtr:otherNames>Gerber PF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0034-5288</gtr:issn><gtr:outcomeId>58c6d316a08c24.26798453</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52276C11-7C92-485F-9D69-84C5F515395F</gtr:id><gtr:title>Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/845a6641ac61a180ca5f79ff6df4e118"><gtr:id>845a6641ac61a180ca5f79ff6df4e118</gtr:id><gtr:otherNames>Tian D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>5a8402be022e12.79253190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87D2D973-8445-4955-BBCB-7857CFC3AA59</gtr:id><gtr:title>Circulation of Porcine Parvovirus Types 1 through 6 in Serum Samples Obtained from Six Commercial Polish Pig Farms.</gtr:title><gtr:parentPublicationTitle>Transboundary and emerging diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94fd5a5174e7b6c084bf6ab351ceefcf"><gtr:id>94fd5a5174e7b6c084bf6ab351ceefcf</gtr:id><gtr:otherNames>Cui J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1865-1674</gtr:issn><gtr:outcomeId>58c6d113034833.65811147</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6366C80C-7551-4E82-8A25-62C5F423CD32</gtr:id><gtr:title>Marek's disease virus infection of phagocytes: a de novo in vitro infection model.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2d2252b37da5bee6a321abaf9907367"><gtr:id>d2d2252b37da5bee6a321abaf9907367</gtr:id><gtr:otherNames>Chakraborty P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>5a9fcd7ba741b0.63753583</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1529782F-5AC8-4FA2-BFE4-954CF5962D3B</gtr:id><gtr:title>Professor Pete Kaiser 1964-2016.</gtr:title><gtr:parentPublicationTitle>Avian pathology : journal of the W.V.P.A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/183721c90fc07d20966ffda279b321e8"><gtr:id>183721c90fc07d20966ffda279b321e8</gtr:id><gtr:otherNames>Stevens M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0307-9457</gtr:issn><gtr:outcomeId>58bd7ae53bb2c4.41871997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>328C20CD-5D83-4D2B-8175-E1FD536597DA</gtr:id><gtr:title>Enhancing heterologous protection in pigs vaccinated with chimeric porcine reproductive and respiratory syndrome virus containing the full-length sequences of shuffled structural genes of multiple heterologous strains.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/845a6641ac61a180ca5f79ff6df4e118"><gtr:id>845a6641ac61a180ca5f79ff6df4e118</gtr:id><gtr:otherNames>Tian D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>5a8402beafad55.62450006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CE9E065-3567-41B3-B9BA-ADA5AB71ECAB</gtr:id><gtr:title>A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dad70ad74f30196ebfe4b49c0360864"><gtr:id>4dad70ad74f30196ebfe4b49c0360864</gtr:id><gtr:otherNames>Matzinger SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>58c6d310132bb2.58660202</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFFEFAE4-345B-4AA4-AEE2-9B9A207AFE2A</gtr:id><gtr:title>Concurrent porcine circovirus type 2a (PCV2a) or PCV2b infection increases the rate of amino acid mutations of porcine reproductive and respiratory syndrome virus (PRRSV) during serial passages in pigs.</gtr:title><gtr:parentPublicationTitle>Virus research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb214b7dc70226de4044c9913d67b9d9"><gtr:id>cb214b7dc70226de4044c9913d67b9d9</gtr:id><gtr:otherNames>Yin SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0168-1702</gtr:issn><gtr:outcomeId>58c6d3167c1758.50144935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7F505F4-26A3-4654-B775-DC4AD9E45FAC</gtr:id><gtr:title>High prevalence and diversity of bovine astroviruses in the faeces of healthy and diarrhoeic calves in South West Scotland.</gtr:title><gtr:parentPublicationTitle>Veterinary microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0d983303f57c39f523a562d71696766"><gtr:id>a0d983303f57c39f523a562d71696766</gtr:id><gtr:otherNames>Sharp CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0378-1135</gtr:issn><gtr:outcomeId>58c7e60be01240.96872138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CE7F1E1-6458-4663-8349-BEB455ABCDB2</gtr:id><gtr:title>Treatable traits and therapeutic targets: Goals for systems biology in infectious disease</gtr:title><gtr:parentPublicationTitle>Current Opinion in Systems Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98b39eadab80fc5f2244370bc628b60d"><gtr:id>98b39eadab80fc5f2244370bc628b60d</gtr:id><gtr:otherNames>Russell C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a72fe872a8321.74876056</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A8F9FFB-8C7F-492A-951B-8790C2092ACD</gtr:id><gtr:title>Hepatitis E virus mixed infection in immunocompetent patient.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/637d2cb4b5d56bc6796319236a381411"><gtr:id>637d2cb4b5d56bc6796319236a381411</gtr:id><gtr:otherNames>Smith DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>56e04eca117a10.86530590</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/D/20241865</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>